PurLite maintains an engineering staff that is comprised of professionals that hold patents and FDA product certifications. They continue to consult with medical professionals and scientists as they develop future products for consumer and commercial markets.

Two independent lab studies and a bacterial study were performed at a major university and a UL certified lab in the US. 

Summaries of these tests include:

A bacterial study proved to be effective on reducing bacteria such as: eColi, Salmonella, Staphylococcus aureus (MRSA or Staph) and Candida albicans (Candida or intestinal and skin bacteria) by 99.99% 

A viral study from proved to be effective on viruses such as H1N1 (swine flu), H5N1 (avian flu), Influenza Type A, Rotavirus, Rhinovirus and Norovirus.

A viral study done from the University of New Hampshire dated March 8, 2017 proved to be effective on cDiff and MRSA.

PurLite is registered with the EPA.

For questions about independent lab studies, email info@purlite.com.